in this issue
Regions :: Western Europe :: Germany
Merck Focuses Resources on Core Activities
12:23 PM MDT | July 27, 2007 | Kate Phillips
Shorter drug development cycles, better cost efficiency, and an increased focus on internal resources are key changes being implemented by Merck’s manufacturing division to respond to challenges facing the pharma industry, says Willie A. Deese, president/manufacturing division at Merck. Deese, who holds responsibility for Merck’s global manufacturing, procurement, and operational excellence functions, spoke at Socma’s luncheon during DCAT week in New York last week. “We’re not changing our business model and our approach to R&D...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee